| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 275.23B | 249.61B | 254.71B | 239.65B | 157.55B | 130.94B |
| Gross Profit | 87.93B | 78.69B | 68.16B | 82.50B | 93.07B | 63.66B |
| EBITDA | 26.21B | 23.63B | 16.73B | 30.28B | 38.63B | 10.00B |
| Net Income | 20.69B | 17.25B | 14.25B | 21.22B | 23.17B | 15.84B |
Balance Sheet | ||||||
| Total Assets | 2.15T | 2.07T | 1.93T | 1.79T | 1.68T | 1.60T |
| Cash, Cash Equivalents and Short-Term Investments | 263.87B | 292.77B | 41.54B | 28.55B | 21.28B | 23.85B |
| Total Debt | 728.14B | 689.53B | 359.49B | 338.99B | 284.55B | 181.72B |
| Total Liabilities | 1.97T | 1.90T | 1.76T | 1.63T | 1.53T | 1.46T |
| Stockholders Equity | 174.05B | 168.41B | 166.33B | 159.53B | 149.78B | 145.62B |
Cash Flow | ||||||
| Free Cash Flow | -112.44B | -93.62B | -9.32B | 32.35B | -106.41B | 138.17B |
| Operating Cash Flow | -104.93B | -91.33B | -177.63M | 41.77B | -102.00B | 142.43B |
| Investing Cash Flow | 56.74B | -5.01B | 83.61B | -17.78B | -19.31B | 20.46B |
| Financing Cash Flow | 56.60B | 117.88B | -23.06B | 21.92B | -1.61B | -36.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $15.78B | 16.04 | 17.06% | 10.44% | -6.79% | 16.13% | |
72 Outperform | $35.69B | 10.39 | 11.78% | 1.80% | 5.89% | 34.68% | |
71 Outperform | $18.83B | 14.76 | 21.29% | 5.63% | -11.64% | -8.75% | |
70 Outperform | $5.00B | 12.00 | 10.91% | 2.17% | -57.78% | -67.92% | |
69 Neutral | $13.55B | 12.10 | 24.13% | 4.44% | 12.43% | 56.30% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $24.04B | 22.92 | 9.34% | 4.74% | 1.13% | -11.93% |
In October 2025, Banco Bradesco S.A. reported no operations involving securities and derivatives for some of its administration and family dependents. However, the Board of Directors engaged in significant transactions involving non-voting shares, purchasing and selling substantial quantities through Ágora C.T.V.M. S/A. These activities reflect the bank’s strategic financial maneuvers, potentially impacting its market position and stakeholder interests.
On November 10, 2025, Banco Bradesco S.A. announced that its indirectly controlled investment company, Atlântica Hospitais e Participações, S.A., signed an Investment Agreement with Rede D’Or São Luiz S.A. Group to include Maternidade São Luiz Star in the ‘Atlântica D’Or’ structure. This expansion, part of a partnership initially disclosed in May 2024, aligns with Atlântica’s strategy to invest in the healthcare value chain. The transaction, which maintains the current ownership structure, is pending regulatory approvals and is expected to enhance Bradesco’s positioning in the healthcare sector.
Banco Bradesco S.A. reported strong financial performance for the third quarter of 2025, with a recurring net income of R$6.2 billion, marking an increase of 2.3% quarter-over-quarter and 18.8% year-over-year. The bank’s revenue reached R$35.0 billion, driven by growth in net interest income, fee and commission income, and insurance operations. The bank maintained stable delinquency rates and improved its credit portfolio quality while continuing its transformation plan to enhance competitiveness and sustainability efforts. Bradesco’s strategic focus on risk-adjusted returns and operational efficiency has resulted in a robust capital position and a stable efficiency ratio.
In the third quarter of 2025, Banco Bradesco S.A. reported significant financial and strategic developments. The bank revised its 2025 income projections upwards for fee and commission income as well as income from insurance and pension plans. Additionally, Bradesco expanded its partnership with Rede D’Or São Luiz S.A. by including Hospital Glória D’Or in its network, reflecting its strategy to invest in the health sector. The bank also approved a substantial interest payment on equity, showcasing its strong financial performance. Bradesco continues to advance its digital transformation, leveraging artificial intelligence to improve customer service and operational efficiency, while introducing new features in its digital banking platforms to enhance user convenience and security.
In the third quarter of 2025, Banco Bradesco SA reported a recurring net income of R$6.2 billion, marking an 18.8% increase year-over-year, driven by strong performances across net interest income, fee and commission income, and insurance operations. The bank’s total revenue rose to R$35.0 billion, with a notable expansion in its loan portfolio, particularly in the MSME and individual segments. Bradesco continued its transformation plan, enhancing client services and focusing on sustainable financing, achieving its socio-environmental target by allocating R$350 billion to beneficial sectors by the end of September 2025. The bank maintained a stable delinquency ratio and robust capital ratios, underscoring its competitive positioning and commitment to long-term growth.
In September 2025, Banco Bradesco S.A. reported no operations involving securities and derivatives for its administration and family dependents. However, the Board of Directors engaged in several transactions involving non-voting shares, purchasing a total of 972,701 shares valued at approximately R$17.15 million. This activity reflects the bank’s strategic decisions regarding its shareholding structure and may impact its market positioning and stakeholder interests.
On September 18, 2025, Banco Bradesco S.A. announced that its Board of Directors approved a proposal for the payment of interim interest on shareholders’ equity totaling R$3 billion. This decision will benefit shareholders registered by September 29, 2025, with payments scheduled by April 30, 2026. The approved interest represents a significant increase, approximately 15.7 times the usual monthly interest, and will contribute to the calculation of mandatory dividends for the year. This move underscores Bradesco’s commitment to enhancing shareholder value and reflects its robust financial position.
In August 2025, Banco Bradesco S.A. reported that there were no operations involving securities and derivatives. This lack of activity might indicate a period of strategic reassessment or market stabilization for the company, potentially impacting its short-term financial strategies and stakeholder expectations.
On September 1, 2025, Banco Bradesco S.A. announced that its indirectly controlled investment company, Atlântica Hospitais e Participações S.A., signed an Investment Agreement with Rede D’Or São Luiz S.A. Group. This agreement involves the inclusion of Hospital Glória D’or into the ‘Atlântica D’Or’ network, maintaining a partnership structure with 50.01% held by Rede D’Or and 49.99% by Atlântica. The expansion aligns with Atlântica’s strategy to invest in the healthcare value chain through partnerships with established hospital operators. The transaction is subject to regulatory approvals and other conditions typical for such operations.